JPMorgan Chase & Co. decreased its position in OR Royalties Inc. (NYSE:OR – Free Report) by 45.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 112,139 shares of the basic materials company’s stock after selling 93,037 shares during the period. JPMorgan Chase & Co. owned about 0.06% of OR Royalties worth $4,495,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Cetera Investment Advisers boosted its position in shares of OR Royalties by 3.5% in the 2nd quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock worth $337,000 after buying an additional 440 shares in the last quarter. Vident Advisory LLC raised its position in OR Royalties by 2.0% during the second quarter. Vident Advisory LLC now owns 42,349 shares of the basic materials company’s stock worth $1,089,000 after acquiring an additional 820 shares during the last quarter. HighTower Advisors LLC raised its position in OR Royalties by 1.4% during the third quarter. HighTower Advisors LLC now owns 79,518 shares of the basic materials company’s stock worth $3,187,000 after acquiring an additional 1,088 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its holdings in shares of OR Royalties by 9.6% in the third quarter. Vanguard Personalized Indexing Management LLC now owns 16,471 shares of the basic materials company’s stock valued at $660,000 after purchasing an additional 1,446 shares in the last quarter. Finally, Verition Fund Management LLC lifted its holdings in shares of OR Royalties by 0.3% in the third quarter. Verition Fund Management LLC now owns 632,705 shares of the basic materials company’s stock valued at $25,359,000 after purchasing an additional 1,949 shares in the last quarter. Hedge funds and other institutional investors own 68.52% of the company’s stock.
OR Royalties Stock Performance
Shares of OR opened at $40.27 on Friday. OR Royalties Inc. has a 1 year low of $18.99 and a 1 year high of $48.06. The company’s 50 day simple moving average is $41.39 and its 200 day simple moving average is $37.95. The company has a market capitalization of $7.56 billion, a price-to-earnings ratio of 36.95 and a beta of 0.83.
OR Royalties Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Tuesday, March 31st will be paid a $0.055 dividend. This represents a $0.22 annualized dividend and a yield of 0.5%. The ex-dividend date is Tuesday, March 31st. OR Royalties’s dividend payout ratio is presently 20.18%.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on OR shares. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of OR Royalties in a research report on Wednesday, February 4th. Scotiabank raised their price target on OR Royalties from $41.00 to $51.00 and gave the stock a “sector perform” rating in a research report on Monday, January 26th. Weiss Ratings reissued a “buy (b)” rating on shares of OR Royalties in a report on Monday, December 29th. Zacks Research downgraded OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Finally, Jefferies Financial Group reaffirmed a “hold” rating and set a $38.00 price objective on shares of OR Royalties in a research note on Sunday, December 7th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $38.25.
Check Out Our Latest Report on OR
About OR Royalties
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
Featured Articles
Want to see what other hedge funds are holding OR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OR Royalties Inc. (NYSE:OR – Free Report).
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
